EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Bioengineered Nanomaterials for siRNA Therapy of Chemoresistant Cancers

Mehdi Sanati, Christian G Figueroa-Espada iD, Emily L Han iD, Michael J Mitchell iD, Saber Amin Yavari iD

ACS Nano · 2024

DOI: 10.1021/acsnano.4c11259 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Nano, 2024. Verfasst von Mehdi Sanati und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Birjand University of Medical Sciences, Birjand 97178, Iran. Hauptthemen laut MEDLINE: RNA, Small Interfering, Neoplasms, Drug Resistance, Neoplasm, Nanostructures. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 357 Literaturangaben. Gefördert von: NCI NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingNeoplasmsDrug Resistance, NeoplasmNanostructuresHumansAnimalsRNA InterferenceGenetic Therapy

Stichwörter der Autor:innen

cancerchemoresistancechemotherapydrug deliverygene therapynanoparticlesnanotechnologysiRNA

Substanzen

RNA, Small Interfering

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Birjand University of Medical Sciences, Birjand 97178, Iran.
  • Department of Bioengineering, University of Pennsylvania, 210 South 33rd Street, Philadelphia, Pennsylvania 19104, United States.
  • Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
  • Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.

ORCID-Profile: Christian G Figueroa-Espada, Emily L Han, Michael J Mitchell, Saber Amin Yavari

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences
  • National Science Foundation Graduate Research Fellowship Program
  • National Cancer Institute
  • National GEM Consortium
  • Division of Chemical, Bioengineering, Environmental, and Transport Systems
  • Burroughs Wellcome Fund

Zitieren

APA

Sanati, M., Figueroa-Espada, C. G., Han, E. L., Mitchell, M. J., & Yavari, S. A. (2024). Bioengineered Nanomaterials for siRNA Therapy of Chemoresistant Cancers. ACS Nano. https://doi.org/10.1021/acsnano.4c11259

Vancouver

Sanati M, Figueroa-Espada CG, Han EL, Mitchell MJ, Yavari SA. Bioengineered Nanomaterials for siRNA Therapy of Chemoresistant Cancers. ACS Nano. 2024. doi:10.1021/acsnano.4c11259

BibTeX
@article{Sanati2024,
  author = {Sanati, Mehdi and Figueroa-Espada, Christian G and Han, Emily L and Mitchell, Michael J and Yavari, Saber Amin},
  title = {Bioengineered Nanomaterials for siRNA Therapy of Chemoresistant Cancers},
  journal = {ACS Nano},
  year = {2024},
  doi = {10.1021/acsnano.4c11259}
}
Kostenlos starten →